Zealand Pharma
365.40 DKK
+2.50 %
Less than 1K followers
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+2.50 %
-15.81 %
-21.66 %
-25.96 %
-19.87 %
-40.10 %
+52.38 %
+85.95 %
+359.62 %
Zealand Pharma operates in biotechnology. Special focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest operations are in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Søborg, Denmark.
Read moreMarket cap
26.13B DKK
Turnover
21.41M DKK
Revenue
9.21B
EBIT %
75.52 %
P/E
3.99
Dividend yield-%
-
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
All
Press releases
ShowingAll content types
Zealand Pharma Announces Financial Results for the Full Year 2025
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools